Millennium Management’s Allied Healthcare Products AHPI Stock Holding History

Millennium Management’s Portfolio AHPI Stock Details AHPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,578	Closed	-$25K	–	7727
2022 Q2	$25K	Buy	+15,578	New	+$35.3K	﹤0.01%	6437

Other funds holding AHPI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

TDC

Thompson Davis & Co Richmond, Virginia $150M AUM 32.35% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Millennium Management's AHPI Position: Q3 2022 in Review

Millennium Management sold out of Allied Healthcare Products (AHPI) in Q3 2022, closing a stake of 15,578 shares — an estimated $25K sold.

Millennium Management first reported a position in AHPI in Q2 2022 and held it in 1 quarter. The position peaked at $25K in Q2 2022. 12 funds tracked by Wall St. Rank hold AHPI as of Q3 2022.

Millennium Management reported no remaining Allied Healthcare Products position as of Q3 2022 after selling out during the quarter.
Millennium Management sold 15,578 Allied Healthcare Products shares in Q3 2022, an estimated $25K.
Millennium Management first reported a position in Allied Healthcare Products in Q2 2022 and held it in 1 quarter.
Millennium Management's Allied Healthcare Products position peaked at $25K in Q2 2022.
12 funds tracked by Wall St. Rank held Allied Healthcare Products as of Q3 2022.

Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.